Pharmaceutical composition comprising monoclonal antibodies...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2171955

The invention relates to pharmaceutical compositions for use as immunomodulator, comprising a purified preparation of a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.

L'invention se rapporte à des compositions pharmaceutiques utilisées en tant qu'immunomodulateurs, comprenant une préparation purifiée d'un anticorps monoclonal dirigé contre le récepteur d'interféron humain de la classe I (IFN-R), et caractérisées par les propriétés suivantes: reconnaissance du domaine extracellulaire de l'INF-R humain, et capacité de neutralisation dressée contre les propriétés biologiques de l'I-IFN de type humain. On a également prévu leur utilisation diagnostique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition comprising monoclonal antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising monoclonal antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising monoclonal antibodies... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1578357

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.